Last reviewed · How we verify

NCT03832075

Validity of Korebalance Balance System

Status unknown NA Last updated 6 February 2019
What this trial tests

NA trial testing Berg Balance Scale in Osteoporosis, Postmenopausal in 53 participants. Status unknown.

Timeline
1 August 2018
Primary endpoint
31 January 2019
28 February 2019

Quick facts

Lead sponsorIstanbul Medeniyet University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment53
Start date1 August 2018
Primary completion31 January 2019
Estimated completion28 February 2019
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Istanbul Medeniyet University

Who can join

50 and older, female only, with Osteoporosis, Postmenopausal or Balance; Distorted. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In postmenopausal osteoporosis patients, the balance is impaired. Equilibrium is evaluated with various test and balance systems. This study aims evaluation of the patients with the Korebalance Balance System and balance tests and investigation the validity of the Korebalance Balance System.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Berg Balance Scale

Trials testing the same drug.

Other recruiting trials for Osteoporosis, Postmenopausal

Currently open trials in the same condition.

Other Istanbul Medeniyet University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03832075.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing